Maurizio Averna
LMU Klinikum(DE)Institut d'Investigació Biomédica de Bellvitge(ES)Istituti Clinici Scientifici Maugeri(IT)Department of Health(ES)Imperial Consultants(GB)Institute for Biomedical Research and Innovation(IT)University of Palermo(AR)Instituto di Biofisica(ES)Instituto Biofisika(ES)Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)University Hospital Cologne(DE)National Research Council(IT)National Research Council(IT)Karl Landsteiner Society(AT)Ludwig-Maximilians-Universität München(DE)University of Genoa(IT)University of Palermo(IT)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipid metabolism and disorders, Cancer, Lipids, and Metabolism, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society(2013)2,699 cited
- → Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events(2015)2,268 cited
- → Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society(2014)1,034 cited
- → Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment(2015)846 cited
- → Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society(2021)833 cited